TOI HC I, LLC

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
18
Insider Sells Sum
$1.82M

Insider Activity of TOI HC I, LLC

The largest sale of all time was on 2022-09-01 and amounted to 41783 shares of The Oncology Institute, Inc. for $251,951.

Biography of TOI HC I, LLC

No biography is available at this moment.

2022-10-17SaleThe Oncology Institute, Inc.
TOI
director
8,249
0.0111%
$4.60$37,945-78.56%
2022-10-14SaleThe Oncology Institute, Inc.
TOI
director
9,800
0.0138%
$4.54$44,492-77.25%
2022-10-13SaleThe Oncology Institute, Inc.
TOI
director
25,200
0.0344%
$4.67$117,684-78.51%
2022-10-12SaleThe Oncology Institute, Inc.
TOI
director
14,343
0.0196%
$4.70$67,412-78.22%
2022-10-11SaleThe Oncology Institute, Inc.
TOI
director
25,000
0.034%
$4.66$116,500-78.13%
2022-10-10SaleThe Oncology Institute, Inc.
TOI
director
21,500
0.0286%
$4.33$93,095-76.96%
2022-10-07SaleThe Oncology Institute, Inc.
TOI
director
14,652
0.0202%
$4.63$67,839-78.09%
2022-10-06SaleThe Oncology Institute, Inc.
TOI
director
33,509
0.0438%
$4.45$149,115-77.99%
2022-10-05SaleThe Oncology Institute, Inc.
TOI
director
14,060
0.019%
$4.78$67,207
2022-10-04SaleThe Oncology Institute, Inc.
TOI
director
23,447
0.032%
$4.85$113,718
2022-10-03SaleThe Oncology Institute, Inc.
TOI
director
16,765
0.0228%
$4.72$79,131
2022-09-30SaleThe Oncology Institute, Inc.
TOI
director
11,000
0.0153%
$4.68$51,480-78.19%
2022-09-07SaleThe Oncology Institute, Inc.
TOI
18,900
0.0251%
$5.80$109,620-82.98%
2022-09-01SaleThe Oncology Institute, Inc.
TOI
41,783
0.0568%
$6.03$251,951-83.25%
2022-08-29SaleThe Oncology Institute, Inc.
TOI
15,000
0.021%
$6.14$92,100-82.37%
2022-08-24SaleThe Oncology Institute, Inc.
TOI
3,525
0.0048%
$6.20$21,855-80.32%
2022-08-19SaleThe Oncology Institute, Inc.
TOI
35,500
0.0479%
$6.53$231,815-80.6%
2022-08-12SaleThe Oncology Institute, Inc.
TOI
16,663
0.0221%
$6.23$103,810-78.65%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.